Goldman Sachs’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Buy |
|
|||||
|
2025
Q1 | $1.18M | Sell |
|
|||||
|
2024
Q4 | $3.35M | Sell |
|
|||||
|
2024
Q3 | $7.85M | Buy |
|
|||||
|
2024
Q2 | $4.3M | Buy |
|
|||||
|
2024
Q1 | $2.2M | Sell |
|
|||||
|
2023
Q4 | $1.92M | Buy |
|
|||||
|
2023
Q3 | $1.44M | Sell |
|
|||||
|
2023
Q2 | $2.21M | Buy |
|
|||||
|
2023
Q1 | $348K | Sell |
|
|||||
|
2022
Q4 | $830K | Buy |
|
|||||
|
2022
Q3 | $635K | Buy |
|
|||||
|
2022
Q2 | $442K | Buy |
|
|||||
|
2022
Q1 | $386K | Sell |
|
|||||
|
2021
Q4 | $671K | Buy |
|
|||||
|
2021
Q3 | $230K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.46M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $202K | Buy |
|